$1.76
-0.04-2.22%
At close: -
$1.76
0.000.00%
After Hours: Dec 20, 4:00 PM EDT
Nautilus Biotechnology reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Nautilus Biotechnology using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-10-29 | $-0.13 | $-0.16 | 18.8 % |
Jun 2024 | 2024-07-30 | $-0.14 | $-0.16 | 12.5 % |
Mar 2024 | 2024-04-30 | $-0.15 | $-0.16 | 6.25 % |
Dec 2023 | 2024-02-28 | $-0.14 | $-0.14 | 0.00 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Mar 2022 | 2022-05-03 | $0 | $170.00K | -100.0 % |
Nautilus Biotechnology (NAUT) is scheduled to report earnings on February 26, 2025. The last reported earnings were for reported on October 29, 2024 for Q3.
The Actual EPS was $-0.13, which beat the estimate of $-0.16.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.